Navigation Links
ULURU Inc. Reports Third Quarter 2013 Financial Results
Date:11/15/2013

ADDISON, Texas, Nov. 15, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced its financial results for the third quarter ended September 30, 2013 and provided a review of its operating activities.

During the third quarter, continued progress was made towards the expansion of commercialization of Altrazeal® in international markets:

  • Orders of Altrazeal® were shipped to five new markets in September and October 2013; the Czech Republic, Slovakia, South Africa, Croatia and Slovenia;
  • Production of Altrazeal® has been initiated in the fourth quarter 2013 for eight additional markets;
  • In September 2013, we executed a License and Supply Agreement with Altrazeal AG to market Altrazeal® in several new territories, to include Africa (markets not already licensed), Latin America, the Commonwealth of Independent States, Georgia, Ukraine, and Turkmenistan. Under the terms of the agreement with Altrazeal AG, we received an up-front licensing payment, will receive certain royalties on product sales within the territories, and will supply Altrazeal® at an agreed upon price; and
  • Since the beginning of the third quarter 2013, we announced the further expansion of the Altrazeal® international marketing network to include 16 additional countries including, Scandinavia, Finland, South Africa, Czech Republic, Slovakia, Portugal, Croatia, and Slovenia.
  • Other noteworthy events include the Company's capital structure being simplified through the redemption of all outstanding shares of preferred stock. In addition, the results of our randomized study were published in the peer reviewed International Wound Journal.

    Commenting on the business activities, Kerry P. Gray, President and CEO, stated, "Outstanding progress has been made on numerous fronts during the past quarter. We believe we are significantly ahead of schedul
    '/>"/>

    SOURCE ULURU Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. ULURU Inc. Announces Conference Call To Discuss Financial Results For The Third Quarter Ended September 30, 2013
    2. ULURU Inc. Completes Redemption Of Preferred Stock
    3. ULURU Inc. Reports Second Quarter 2013 Financial Results
    4. ULURU Inc. Announces Conference Call To Discuss Financial Results For The Second Quarter Ended June 30, 2013
    5. ULURU Inc. Reports First Quarter 2013 Financial Results
    6. ULURU Inc. Announces Conference Call To Discuss Financial Results For The First Quarter Ended March 31, 2013
    7. ULURU Inc. Reports Financial Results For Fourth Quarter And Year Ending December 31, 2012
    8. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2012 and to Provide a Business Update
    9. ULURU Inc. Business Update And Outlook
    10. ULURU Inc. Announces Closing Of $440,000 Private Placement
    11. ULURU Inc. Reports Third Quarter 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... , Dec. 19, 2014   Hospira, Inc. ... of injectable drugs and infusion technologies, today announced that ... Annual Healthcare Conference on Wednesday, Jan. 14, 2015, in ... scheduled to begin at 10:30 a.m. Pacific time on ... all interested parties through a live audiocast accessible via ...
    (Date:12/19/2014)...  Monarch America Inc. (OTCQB: CANK) ("Monarch America" or ... provide this review of the Company,s recent achievements and ... "Over this past year, we achieved many of our ... to say that Monarch America is in a stronger ... been," stated Eric Hagen , CEO of Monarch ...
    (Date:12/19/2014)... 2014 Somewhere between dropping five pounds and ... But Audicus , a next-generation hearing aids company, ... year. Hearing loss is the third most ... it is often unaddressed. Forty-eight million Americans have hearing ... aid, mainly due to price. Hearing aids traditionally cost ...
    Breaking Medicine Technology:Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3Audicus Will Help People Resolve to Hear Better in 2015 2
    ... DIEGO, Aug. 8, 2011 CareFusion Corp. (NYSE: ... results for the quarter and fiscal year ended June 30, ... Prevention businesses, gross margin expansion and the benefit of strong ... earnings for the quarter and for the year," said Kieran ...
    ... Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) ... June 30, 2011. Quarterly Financial Highlights ... revenue for NUEDEXTA® of $2.2 million Cash, cash equivalents, and ... "I am thrilled with the progress we are making ...
    Cached Medicine Technology:CareFusion Reports Fourth Quarter and Fiscal 2011 Results 2CareFusion Reports Fourth Quarter and Fiscal 2011 Results 3CareFusion Reports Fourth Quarter and Fiscal 2011 Results 4CareFusion Reports Fourth Quarter and Fiscal 2011 Results 5CareFusion Reports Fourth Quarter and Fiscal 2011 Results 6CareFusion Reports Fourth Quarter and Fiscal 2011 Results 7CareFusion Reports Fourth Quarter and Fiscal 2011 Results 8CareFusion Reports Fourth Quarter and Fiscal 2011 Results 9CareFusion Reports Fourth Quarter and Fiscal 2011 Results 10CareFusion Reports Fourth Quarter and Fiscal 2011 Results 11CareFusion Reports Fourth Quarter and Fiscal 2011 Results 12CareFusion Reports Fourth Quarter and Fiscal 2011 Results 13CareFusion Reports Fourth Quarter and Fiscal 2011 Results 14CareFusion Reports Fourth Quarter and Fiscal 2011 Results 15Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results 2Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results 3Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results 4Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results 5Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results 6Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results 7Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results 8
    (Date:12/21/2014)... 2014 Parker & Sons, Inc. a ... plumbing and other similar home contractor services announces a ... to its expert contracting services. The company is considered ... been serving Arizona for well over 40 years. Parker ... best in quality customer service to the residents and ...
    (Date:12/21/2014)... 21, 2014 As testosterone therapy ... attacks, stroke and blood clots from using testosterone products ... new study shows that the male hormone testosterone may ... a study published in the Proceedings of the National ... examined a group of male rats with naturally occurring ...
    (Date:12/20/2014)... is a professional company offering many kinds of ... its new engineered bamboo flooring collection, and announced a ... BambooIndustry.com’s customers come from many countries in the world: ... CEO of the company, the global bamboo flooring market ... years, and the demand for eco-friendly bamboo flooring products ...
    (Date:12/20/2014)... NY (PRWEB) December 20, 2014 An ... healthcare sector have benefited the Massage Services ... discretionary characteristics of industry products, the anticipated 1.0% annualized ... period has provided consumers with the means to afford ... have received a massage in a given year has ...
    (Date:12/20/2014)... holidays can be anything but joyous for people with ... and other allergy triggers. "The dust from the ... away in dank basements or dusty attics is triggering ... Shah, an affiliate faculty member at Loyola University Chicago ... Shah, who is also an allergist at Gottlieb ...
    Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Holiday Trimmings Can Trigger Allergies 2
    ... can increase cancer growth, cause stroke and heart attacks, ... -- The U.S. Food and Drug Administration on Thursday ... agents, which are drugs used to treat certain types ... Epogen and Procrit, and detail their dangers to patients ...
    ... Dean of the Harvard School of Public Health (HSPH), ... Rotterdam in the Netherlands. , The University annually ... founding, a celebration called Dies Natalis. Last years awardees ... 2003 Nobel Prize in Economics, and Professor Arnold Zellner, ...
    ... Wyeth (NYSE: WYE ),announced today that it will ... Tuesday, November 13, 2007 at 11:00 a.m. Eastern,Time. Presenting ... President,Wyeth and President, Wyeth Pharmaceuticals Global Business. Wyeth,s ... and available for replay following the conference. ...
    ... Howard G. Smith,announces a December 3, 2007, deadline to ... action lawsuit filed on behalf of shareholders who,purchased the ... MEND ) between February 12, 2007 and September ... pending in,the United States District Court for the Southern ...
    ... Nov. 8 Medical Mutual and Ohio Farm ... provide quality,affordable health insurance to OFBF,s more than ... Bureau members will gain access to,Medical Mutual,s SuperMed ... and other medical service providers in Ohio. Medical,Mutual ...
    ... Calif., November 8 NeurogesX, Inc.,(Nasdaq: NGSX ), ... management therapies, today announced it will,report results for its ... the market closes. A conference call to review ... PT) on November 14, 2007 and will be hosted ...
    Cached Medicine News:Health News:FDA Issues New Warnings for Anemia Drugs 2Health News:FDA Issues New Warnings for Anemia Drugs 3Health News:HSPH Dean Barry R. Bloom to receive honorary doctorate from Erasmus University Rotterdam 2Health News:Ohio Farm Bureau Health Plan Awarded to Medical Mutual of Ohio 2Health News:Ohio Farm Bureau Health Plan Awarded to Medical Mutual of Ohio 3Health News:NeurogesX to Report Third Quarter 2007 Financial Results on November 14, 2007 2Health News:NeurogesX to Report Third Quarter 2007 Financial Results on November 14, 2007 3
    ... HEp-2000 ANA uses a patented HEp-2 ... to increase the sensitivity to SS-A/Ro autoantibodies, ... Several independent studies have been published worldwide ... increased sensitivity to SS-A/Ro autoantibodies when used ...
    ... The ANA and ENA assays ... patients negative for antinuclear antibodies, which ... diseases such as Systemic lupus erythematosus ... disease, progressive systemic sclerosis, scleroderma, polymyositis, ...
    ... The ANA and ENA assays can ... negative for antinuclear antibodies, which are ... such as Systemic lupus erythematosus (Lupus), ... progressive systemic sclerosis, scleroderma, polymyositis, dermatomyositis, ...
    ... Indirect Fluorescence Assay (IFA) for IgG ... for the qualitative and semi-quantitative detection ... in human serum. Detection of ANA ... an aid in the diagnosis of ...
    Medicine Products: